SCT and depressive symptom measurement: The potential role of the calcitonin-AMYR axis in depression has been delineated by exploiting both agonists (e.g., sCT) and inhibitors/antagonists of AMYR (e.g., AC187; Hay et al., 2005; Jiang et al., 2022).